Clinical Professor Steven Boyages PhD FRACP FAFPHM DDU
Professor Steven Boyages is currently the Medical Director for eHealth NSW. Previously Steven was the Foundation Chief Executive of the Clinical Education and Training Institute (CETI) of NSW. Steven was formerly the Chief Executive of the Sydney West Area Health Service (SWAHS) and has professorial appointments to the University of Sydney and the University of Western Sydney. [More...]
Professor Steven Boyages is currently the Medical Director for eHealth NSW. Previously Steven was the Foundation Chief Executive of the Clinical Education and Training Institute (CETI) of NSW. Steven was formerly the Chief Executive of the Sydney West Area Health Service (SWAHS) and has professorial appointments to the University of Sydney and the University of Western Sydney.
CETI was established as one of the four pillars to reform health as part of the recommendations of the Garling inquiry into acute care services. The functions of CETI are tp provide leradership to ensure the development and the delivery of clinical education and training across the NSW public health system which:
a. supports safe, high quality, multi-disciplinary team based, patient centred care
b. meets service delivery needs and operational requirements; and
c. enhances workforce skills, flexibility and productivity.
In the former role as CE of SWAHS employed over 15,000 staff, covers a population of 1.2 million people and has a gross operating budget of $2.0 billion and manages $ 1.6 billion worth of assets. The Area extended from Auburn to Lithgow local government authorities approximately the size of Holland. He was appointed CEO of the former Western Sydney AHS in 2002. The AHS was broken into two local health networks at the end of 2010 as part of the National Health Reform agenda.
Steven is a unique hybrid of clinician manager who continues to work in the clinical field of endocrinology. He was previously the Director of Diabetes and Endocrinology at Westmead Hospital from 1990 to 1999. In that role his major achievements were to define the pathophysiology of thyroid hormone deficiency on brain development secondary to iodine deficiency; to develop prevention strategies in iodine deficient communities in China, India, Indonesia and Northern Italy; to define the impact of Growth Hormone excess and deficiency in adults and to develop innovative population health models of care for people with diabetes. Steven continues an active research career in a range of domains, but mostly in the pursuit of better models of chronic disease prevention and management.
Steven previously was the foundation director of the Centre for Research and Clinical Policy in NSW Health in 1999. During that time he established the Priority Health Programs funded to the tune of $15 million per annum; doubled the Research Infrastructure Grants Program; established the Quality Branch of NSW Health and was appointed as Clinical Advisor to the Director General to implement the Government Action Plan for Health Reform. Steven was also instrumental in establishing and securing funding for the State's biotechnology strategy BioFirst, a $150 million investment.
Steven's current interests are varied and include the application of health technology to health care delivery, in particular the development of IT applications that add value to the enterprise, to the community and to the patient. Steven's teams have developed sophisticated web based business information tools that allow real time enterprise monitoring. In addition, Steven has pioneered innovative models of organizational design, and re-engineered clinical models of care. Most importantly his chief interest is providing the best possible care to patients, their carers and to the communities he serves. [Hide detail]
Professor Steven Boyages is a world authority on the impact of iodine nutrition in at risk populations. His PhD thesis established the basis to understanding the impact of iodine deficiency acting through maternal and fetal thyroid hormone deficiency on the developing fetal brain. This thesis led to a range of other studies, in vitro and at the population level that adopted universal iodisation of food as the preferred method to prevent these devastating disorders.
His studies also led to an understanding of the effects of iodine excess at the cellular level and in human studies. In particular he developed an animal model for the study of the effects of amiodarone on thyroid and other tissues. Further research revealed new knowledge in how iodine impairs cell proliferation as well as the mechanism of cytotoxicity of various forms of iodine on thyroid follicular cells.
Further research interests include, understanding the cellular mechanisms of action of GH and somatostatin;
Current national competitive grants*
The effect of a coordinated care intervention, Care Navigation, on the readmission rate of chronically ill patients at Nepean Hospital.
Leeder S, Gillespie J, Usherwood T, Boyages S
National Health and Medical Research Council Project Grant ($702,630 over 4 years)
* Grants administered through the University of Sydney